GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tribute Pharmaceuticals Canada Inc (OTCPK:TBUFF) » Definitions » FCF Yield %

Tribute Pharmaceuticals Canada (Tribute Pharmaceuticals Canada) FCF Yield % : 0.00 (As of Apr. 29, 2024)


View and export this data going back to . Start your Free Trial

What is Tribute Pharmaceuticals Canada FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Tribute Pharmaceuticals Canada's Trailing 12-Month Free Cash Flow is $-35.55 Mil, and Market Cap is $117.40 Mil. Therefore, Tribute Pharmaceuticals Canada's FCF Yield % for today is 0.00%.

The historical rank and industry rank for Tribute Pharmaceuticals Canada's FCF Yield % or its related term are showing as below:


TBUFF's FCF Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: -0.63
* Ranked among companies with meaningful FCF Yield % only.

Tribute Pharmaceuticals Canada's FCF Margin % for the quarter that ended in Sep. 2015 was -7.01%.


Tribute Pharmaceuticals Canada FCF Yield % Historical Data

The historical data trend for Tribute Pharmaceuticals Canada's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tribute Pharmaceuticals Canada FCF Yield % Chart

Tribute Pharmaceuticals Canada Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.35 -4.69 -17.49 -26.87 -68.79

Tribute Pharmaceuticals Canada Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.13 -244.22 -12.03 -14.06 -1.89

Competitive Comparison of Tribute Pharmaceuticals Canada's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Tribute Pharmaceuticals Canada's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tribute Pharmaceuticals Canada's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tribute Pharmaceuticals Canada's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Tribute Pharmaceuticals Canada's FCF Yield % falls into.



Tribute Pharmaceuticals Canada FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Tribute Pharmaceuticals Canada's FCF Yield % for the fiscal year that ended in Dec. 2014 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-29.895 / 43.459052
=-68.79%

Tribute Pharmaceuticals Canada's annualized FCF Yield % for the quarter that ended in Sep. 2015 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.476 * 4 / 100.9928
=-1.89%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tribute Pharmaceuticals Canada FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Tribute Pharmaceuticals Canada FCF Yield % Related Terms

Thank you for viewing the detailed overview of Tribute Pharmaceuticals Canada's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tribute Pharmaceuticals Canada (Tribute Pharmaceuticals Canada) Business Description

Traded in Other Exchanges
N/A
Address
Tribute Pharmaceuticals Canada Inc was incorporated under the Business Corporations Act (Ontario) on November 14, 1994. The Company is a specialty pharmaceutical company. It conducts acquisition, licensing, development and promotion of healthcare products in Canada. It sells Uracyst and NeoVisc internationally through a number of strategic partnerships. The Company's portfolio of assets includes nine product lines, eight of which are on the market in Canada, including: NeoVisc, NeoVisc Single Dose, Uracyst, BladderChek, Bezalip SR, Soriatane, Cambia, Daraprim, Collatamp G, and MycoVa. The Company markets its products in Canada through its own sales force and currently has licensing agreements for the distribution of select products in over 20 countries, and continues to expand this footprint. It faces product competition from companies marketing competing pharmaceutical products and medical devices in Canada. The Company's operations are or may be subject to various federal, provincial, state and local laws, regulations and recommendations relating to the marketing of products and relationships with treating physicians, data protection, safe working conditions, laboratory and manufacturing practices, the export of products to certain countries and the purchase, storage, movement, use and disposal of hazardous or potentially hazardous substances.
Executives
John M Gregory director, 10 percent owner
Sj Strategic Investments Llc 10 percent owner
Joan P Gregory other: Member 340 EDGEMONT AVE., SUITE 500, BRISTOL TN 37620
James M Gregory other: Member 340 EDGEMONT AVE., SUITE 500, BRISTOL TN 37620
Susan Gregory other: Member 340 MARTIN LUTHER KING, JR. BLVD, SUITE 200, BRISTOL TN 37620

Tribute Pharmaceuticals Canada (Tribute Pharmaceuticals Canada) Headlines

No Headlines